We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-6 of 6

Irish competition law: concept of undertaking

  • A&L Goodbody
  • -
  • Ireland
  • -
  • March 21 2011

On 8 March 2011, the High Court (Cooke J.) determined that the HSE was an "undertaking" for the purposes of competition law when engaged in arranging or providing ambulance and other means of transport for patients to and from hospitals and other health facilities in the State

2012 report on pharmaceuticals delivery in Ireland: "delivery of pharmaceuticals in Ireland - getting a bigger bang for the buck"

  • A&L Goodbody
  • -
  • Ireland
  • -
  • February 14 2012

Ireland's Health Service Executive (HSE) recently commissioned and funded a report from the Economic and Social Research Institute (ESRI

BUPA loses Irish state aid appeal

  • Shepherd & Wedderburn LLP
  • -
  • European Union, Ireland
  • -
  • February 29 2008

On 12 February, the Court of First Instance (CFI) issued its judgment in Case T-28903, dismissing an application by BUPA to annul a decision of the European Commission (the Commission) in respect of a risk equalisation system for the private medical insurance sector in Ireland

Provision of emergency services found not to breach EU law

  • Nabarro LLP
  • -
  • European Union, Ireland
  • -
  • January 30 2008

On 18 December 2007, the European Court of Justice (ECJ) (in Case C-53203), overturned the European Commission's (Commission) decision regarding the Eastern Regional Health Authority (Authority

Competition Authority identifies necessary reforms in GP services

  • A&L Goodbody
  • -
  • Ireland
  • -
  • May 19 2010

The Competition Authority has published the first two parts of its report on General Medical Practitioners

Commission consults on EU transparency rules in relation to pricing and reimbursement of medicines

  • Matheson
  • -
  • European Union, Ireland
  • -
  • May 2 2011

European Member States are responsible for their own health insurance schemes and for determining the pricing for medicines and their reimbursement status